3MG BIOMEDICAL LTD
- 86220Specialist medical practice activities
- 86900Other human health activities
Opportunity 76/100 (strong), bankability 65/100. Same-surname younger director in place — likely family handover, not open to sale. Share purchase looks the cleaner deal structure. Most likely exit: share sale to pe / searcher (65/100).
Data confidence
Overall: low (53/100)Sparse data coverage. Treat AI-generated outputs as preliminary. Manual diligence essential.
Solid opportunity signal. Worth a dedicated memo and management meeting.
Recent activity
- • 1 confirmation-statement
Corporate timeline (6 events)Click to expand
- 2025-09-24➕GLOVER, Mia appointeddirector
- 2025-09-24📄appoint-person-director-company-with-name-dateofficers · AP01
- 2025-02-26🏢Company incorporatedAs 3MG BIOMEDICAL LTD
- 2025-02-26➕GLOVER, Mark Alec, Dr appointedsecretary
- 2025-02-26➕GLOVER, Mark Alec, Dr appointeddirector
- 2025-02-26📄incorporation-companyincorporation · NEWINC
Owner dependency
Material founder dependency. Consider a 2-3 year earn-out and build in a handover plan before completion.
- +Two-director setup: Only two active directors — typical of owner-managed SMEs but limits succession.
- +Senior director age: Director aged approximately 63 — approaching natural succession window.
- +Family involvement: Multiple officers share a surname — likely family business, which concentrates governance.
- +Young company: Only 1.3 years old — management layer unlikely to be developed.
Succession & seller-readiness
No meaningful acquirability indicators from public data.
- primaryFamily succession underway: Not a takeover target — GLOVER, Mia (same surname) appointed 2025-09-24. Pattern consistent with intra-family handover.
- primaryFounder aged 63+: Senior director is approximately 63. Approaching typical UK retirement age — succession thinking likely.
- secondaryTwo-director governance: Small-team governance. Succession depth is thin but not absent.
Red flags
cleanShareholders & ownership
1 active beneficial owner| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Dr Mark Alec Glover Individual · British · DOB 05/1963 · age 63 | 50–75% | 50–75% | 50-75% shares · 50-75% voting | 26/02/2025 |
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Similar companies
Active · Professional services · WC postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| 3YESSS LTD→ 15923212 · est 2024 · no financials extracted | — | — | — | — | 1y | — | — |
| 411V1111 LIMITED→ 16891891 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| 4FT INVEST LTD→ 16615146 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| 7 HOPES LTD→ 11403027 · est 2018 · no financials extracted | — | — | — | — | 7y | — | — |
| 7072 CONSULTING LIMITED→ 15525680 · est 2024 · no financials extracted | — | — | — | — | 2y | — | — |
| 720 CAPITAL LTD→ 16707606 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| 7EVEN VENTURES LTD→ 17012973 · est 2026 · no financials extracted | — | — | — | — | — | — | — |
| 7POINT7 LTD→ 16868881 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| 84BY LTD→ 16843819 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| 89 NORTH LTD→ 16933816 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| 8LBS LIMITED→ 07688630 · est 2011 · no financials extracted | — | — | — | — | 14y | — | — |
| 8POD MANAGEMENT LTD→ 16535933 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
7 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (3 active · 0 resigned)
Click a director name to see their full track record across all companies.